Effects of betamethasone on maternal plasma corticotropin releasing factor, ACTH and cortisol during pregnancy

P. J. Tropper, R. S. Goland, S. L. Wardlaw, H. E. Fox, A. G. Frantz

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Corticotropin releasing factor immunoactivity (CRFi) has been identified in the plasma of women in the second half of gestation. There are several lines of evidence supporting a placental source for this hormone. Regulation of placental CRFi is poorly understood. In this study, the effect of a long-acting glucorticoid on the release of placental CRFi was investigated. Elevent women in the third trimester of pregnancy had plasma samples measured for CRFi, ACTH and cortisol before and after receiving 12 mg betamethasone. There was a significant decrease in ACTH (p < 0.05) and cortisol levels (p < 0.01) but no change in CRFi. It is concluded that the secretion of CRFi by the placenta is not inhibited by the administration of betamethasone while maternal levels of cortisol and ACTH are lowered. These results suggest that the acute regulation of placental CRFi is distinct from the regulation of hypothalamic CRF.

Original languageEnglish (US)
Pages (from-to)221-225
Number of pages5
JournalJournal of Perinatal Medicine
Volume15
Issue number3
StatePublished - 1987
Externally publishedYes

Fingerprint

Betamethasone
Corticotropin-Releasing Hormone
Adrenocorticotropic Hormone
Hydrocortisone
Mothers
Pregnancy
Placental Hormones
Third Pregnancy Trimester
Placenta

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

Tropper, P. J., Goland, R. S., Wardlaw, S. L., Fox, H. E., & Frantz, A. G. (1987). Effects of betamethasone on maternal plasma corticotropin releasing factor, ACTH and cortisol during pregnancy. Journal of Perinatal Medicine, 15(3), 221-225.

Effects of betamethasone on maternal plasma corticotropin releasing factor, ACTH and cortisol during pregnancy. / Tropper, P. J.; Goland, R. S.; Wardlaw, S. L.; Fox, H. E.; Frantz, A. G.

In: Journal of Perinatal Medicine, Vol. 15, No. 3, 1987, p. 221-225.

Research output: Contribution to journalArticle

Tropper, PJ, Goland, RS, Wardlaw, SL, Fox, HE & Frantz, AG 1987, 'Effects of betamethasone on maternal plasma corticotropin releasing factor, ACTH and cortisol during pregnancy', Journal of Perinatal Medicine, vol. 15, no. 3, pp. 221-225.
Tropper, P. J. ; Goland, R. S. ; Wardlaw, S. L. ; Fox, H. E. ; Frantz, A. G. / Effects of betamethasone on maternal plasma corticotropin releasing factor, ACTH and cortisol during pregnancy. In: Journal of Perinatal Medicine. 1987 ; Vol. 15, No. 3. pp. 221-225.
@article{48a531be4fc34e6aa6f451b028142d33,
title = "Effects of betamethasone on maternal plasma corticotropin releasing factor, ACTH and cortisol during pregnancy",
abstract = "Corticotropin releasing factor immunoactivity (CRFi) has been identified in the plasma of women in the second half of gestation. There are several lines of evidence supporting a placental source for this hormone. Regulation of placental CRFi is poorly understood. In this study, the effect of a long-acting glucorticoid on the release of placental CRFi was investigated. Elevent women in the third trimester of pregnancy had plasma samples measured for CRFi, ACTH and cortisol before and after receiving 12 mg betamethasone. There was a significant decrease in ACTH (p < 0.05) and cortisol levels (p < 0.01) but no change in CRFi. It is concluded that the secretion of CRFi by the placenta is not inhibited by the administration of betamethasone while maternal levels of cortisol and ACTH are lowered. These results suggest that the acute regulation of placental CRFi is distinct from the regulation of hypothalamic CRF.",
author = "Tropper, {P. J.} and Goland, {R. S.} and Wardlaw, {S. L.} and Fox, {H. E.} and Frantz, {A. G.}",
year = "1987",
language = "English (US)",
volume = "15",
pages = "221--225",
journal = "Journal of Perinatal Medicine",
issn = "0300-5577",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "3",

}

TY - JOUR

T1 - Effects of betamethasone on maternal plasma corticotropin releasing factor, ACTH and cortisol during pregnancy

AU - Tropper, P. J.

AU - Goland, R. S.

AU - Wardlaw, S. L.

AU - Fox, H. E.

AU - Frantz, A. G.

PY - 1987

Y1 - 1987

N2 - Corticotropin releasing factor immunoactivity (CRFi) has been identified in the plasma of women in the second half of gestation. There are several lines of evidence supporting a placental source for this hormone. Regulation of placental CRFi is poorly understood. In this study, the effect of a long-acting glucorticoid on the release of placental CRFi was investigated. Elevent women in the third trimester of pregnancy had plasma samples measured for CRFi, ACTH and cortisol before and after receiving 12 mg betamethasone. There was a significant decrease in ACTH (p < 0.05) and cortisol levels (p < 0.01) but no change in CRFi. It is concluded that the secretion of CRFi by the placenta is not inhibited by the administration of betamethasone while maternal levels of cortisol and ACTH are lowered. These results suggest that the acute regulation of placental CRFi is distinct from the regulation of hypothalamic CRF.

AB - Corticotropin releasing factor immunoactivity (CRFi) has been identified in the plasma of women in the second half of gestation. There are several lines of evidence supporting a placental source for this hormone. Regulation of placental CRFi is poorly understood. In this study, the effect of a long-acting glucorticoid on the release of placental CRFi was investigated. Elevent women in the third trimester of pregnancy had plasma samples measured for CRFi, ACTH and cortisol before and after receiving 12 mg betamethasone. There was a significant decrease in ACTH (p < 0.05) and cortisol levels (p < 0.01) but no change in CRFi. It is concluded that the secretion of CRFi by the placenta is not inhibited by the administration of betamethasone while maternal levels of cortisol and ACTH are lowered. These results suggest that the acute regulation of placental CRFi is distinct from the regulation of hypothalamic CRF.

UR - http://www.scopus.com/inward/record.url?scp=0023271221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023271221&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 221

EP - 225

JO - Journal of Perinatal Medicine

JF - Journal of Perinatal Medicine

SN - 0300-5577

IS - 3

ER -